SHAREHOLDER CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Deadline on August 4, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Grail To Contact Him Directly To Discuss Their... Read more.
Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym®
New data from CATALYST and MOMENTUM trials presented at American Diabetes Association’s (ADA) 86th Scientific Sessions In the CATALYST trial, patients with hypercortisolism... Read more.
SES AI Corporation Class Action Reminder – Robbins LLP Encourages SES Investors to Contact the Firm for Information About Their Rights
Robbins LLP is Investigating Allegations that SES AI Corporation (SES) Misled Investors Regarding its Business Prospects SAN DIEGO–(BUSINESS WIRE)–$SES... Read more.
Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
Dexcom sponsored CONNECT randomized controlled trial expected to help establish new standard of care for CGM use by people with Type 2 diabetes not using insulin... Read more.
Kalloghlian Myers LLP: Potential Investor Class Action Against TerraVest Industries Inc.
TORONTO–(BUSINESS WIRE)–Kalloghlian Myers LLP is investigating a potential investor class action against TerraVest Industries Inc. (TSE: TVK). On June... Read more.
Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide
Results from multiple Phase 2b dose finding studies for berobenatide (PF’3944) highlight a potential first-in-class monthly GLP-1 receptor agonist (GLP-1 RA) peptide,... Read more.
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care
STRIVE pivotal trial shows Omnipod 6 achieved strong glycemic outcomes with fewer boluses, across age groups and diabetes types EVOLUTION 3 feasibility study demonstrates... Read more.
Investor Notice: Robbins LLP Informs Investors of the PicS N.V. Class Action
SAN DIEGO–(BUSINESS WIRE)–$PICS #Banking—Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased... Read more.
Command the Clone Wars’™ Most Cunning Operatives in Star Wars Zero Company™, Launching August 27
Watch the Official Gameplay Trailer Showcasing a New Take on Turn-Based Tactics Games; Pre-Orders Now Available for PC, PlayStation 5, Xbox Series X|S REDWOOD CITY,... Read more.
FINAL FANTASY VII REVELATION Announced — Experience the Journey’s End in Spring 2027
Explore a World Without Boundaries Alongside Unforgettable Allies in the Thrilling Conclusion of the FINAL FANTASY VII Remake Saga Launching Simultaneously for PlayStation... Read more.